The Zhitong Finance App learned that on Tuesday, STAAR Surgical (STAA.US) surged more than 15% in the premarket to $27.15. According to the news, Alcon said it had raised its offer to acquire STAAR Surgical to a total equity value of about $1.6 billion, up from the previous $1.5 billion. Under the terms of the revised agreement, Alcon will purchase all STAAR Surgical's outstanding shares in cash at a price of $30.75 per share, above its previous offer of $28 per share. Alcon said the deal now represents a 74% premium over STAAR's volume-weighted average price over the past 90 days and a 66% premium over the closing price of STAAR shares on August 4 (the day before the merger was announced).